The current state of omnichannel initiatives in the life sciences industry has often been characterized by incremental effectiveness, high costs, complexity, siloed approaches and slow progress. This is not a condemnation of the omnichannel concept, but…
The distinctly crucial role Medical Science Liaisons (MSLs) play in the healthcare industry helps ensure success for all stakeholders involved in a patient’s treatment journey. MSLs play a significant role in bridging the gap between scientific…
In the intricate web of pharmaceuticals, a groundbreaking transformation is underway – one that marries data analytics with digital therapy, reshaping the industry’s landscape fundamentally. As the dust settles from the FDA Symposium, a seismic shift…
The pharmaceutical industry continues to face a multitude of changes that have the potential to directly impact launch strategy. From more recent tangible trends like a rise in cost-containment policies, to ongoing net price transparency forces…
Authors: Robin Arnold, Executive Vice President; Renyang Liu, Engagement Manager; Erica Wang, Associate Consultant Background Internet healthcare means using the internet to provide health and medical services. China has implemented “Internet Plus Healthcare” as a national…
Noticeable improvements in several relationship competencies separate the top companies from the rest of the industry. Post-pandemic industry dynamics have forced a shift in the way pharmaceutical companies call on their managed care customers. This past…
In the dynamic realm of pharmaceuticals, staying ahead of the curve is not just an advantage; it’s a necessity. Recently, our team had the privilege of attending the CDER’s Office of Pharmaceutical Quality (OPQ) symposium, where…
Amazon Web Services and EVERSANA are partners at the epicenter of transforming life sciences commercialization through technology solutions including AI. Experts Scott Snyder, Chief Digital Officer, EVERSANA, and Dr. Shakthi Kumar, Worldwide Head, Healthcare and Life…
Fewer than 60% of Pharmacy Benefit Manager (PBM) electronic benefit verifications (eBVs) accurately assess patients’ financial responsibilities, largely due to the industry’s reliance on AI algorithms for estimations. This leads to financial barriers for patients, hesitancy…
In April, the European Federation of Pharmaceutical Industries and Associations’ (EFPIA) 2022 Patient W.A.I.T Indicator found that the average rate of availability for pharmaceuticals in Europe is 45%, down 2% on the previous year. Additionally, the…